Minimizing IP issues associated with gene constructs encoding the Bt toxin - a case study

Md Mahmudul Hassan,Francis Tenazas,Adam Williams,Jing-wen Chiu,Charles Robin,Derek A. Russell,John F. Golz
DOI: https://doi.org/10.1186/s12896-024-00864-3
2024-06-05
BMC Biotechnology
Abstract:As part of a publicly funded initiative to develop genetically engineered Brassicas (cabbage, cauliflower, and canola) expressing Bacillus thuringiensis Crystal ( Cry )-encoded insecticidal (Bt) toxin for Indian and Australian farmers, we designed several constructs that drive high-level expression of modified Cry1B and Cry1C genes (referred to as Cry1B M and Cry1C M ; with M indicating modified). The two main motivations for modifying the DNA sequences of these genes were to minimise any licensing cost associated with the commercial cultivation of transgenic crop plants expressing Cry M genes, and to remove or alter sequences that might adversely affect their activity in plants.
biotechnology & applied microbiology
What problem does this paper attempt to address?